TAYSHA GENE THERAPIES INC
TSHA·877619106·US·Common Stock·Healthcare - Biotechnology-Activist
TSHA (TAYSHA GENE THERAPIES INC) is held by 117 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($105.3M), GOLDMAN SACHS GROUP INC ($100M), Avoro Capital Advisors LLC ($97M). Net institutional sentiment: Mixed.
117
Holders
Avg rating(26 Elite)
$920.1M
Total Value
55% (130)
Fund Consensus
60 buying - 50 selling
Who's Trading
InsiderNSNagendran SukumarSell $1.2MJul 10, 2026
ActivistVPVestal Point Capital, LP6.3%May 15, 2026
InsiderNSNagendran SukumarSell $892KApr 10, 2026
InsiderNPNolan Sean P.Sell $190KJan 26, 2026
InsiderAKAlam KamranSell $110KJan 26, 2026
InsiderNSNagendran SukumarSell $124KJan 26, 2026
InsiderNPNolan Sean P.Sell $650KJan 23, 2026
InsiderAKAlam KamranSell $375KJan 23, 2026
13F: Insider & Congress:
Showing 1-20 of 130
1 / 7
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer